Chromadex Corp’s recently made public that its Chief Financial Officer Gerber Brianna acquired Company’s shares for reported $7050.0 on Dec 01 ’23. In the deal valued at $1.41 per share,5,000 shares were bought. As a result of this transaction, Gerber Brianna now holds 27,436 shares worth roughly $0.11 million.
Then, Jaksch Frank L Jr bought 7,000 shares, generating $11,830 in total proceeds. Upon buying the shares at $1.69, the Director now owns 231,339 shares.
Before that, Fried Robert N bought 7,000 shares. Chromadex Corp shares valued at $9,940 were divested by the Chief Executive Officer at a price of $1.42 per share. As a result of the transaction, Fried Robert N now holds 95,001 shares, worth roughly $0.37 million.
Oppenheimer downgraded its Chromadex Corp [CDXC] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who decreased its forecast for the stock in mid August from “a Buy” to “a Neutral”. ROTH Capital began covering CDXC with “Buy” recommendation on March 08, 2022. Oppenheimer started covering the stock on October 16, 2019. It rated CDXC as “an Outperform”.
Price Performance Review of CDXC
On Tuesday, Chromadex Corp [NASDAQ:CDXC] saw its stock jump 0.25% to $3.94. Over the last five days, the stock has lost -1.01%. Chromadex Corp shares have risen nearly 175.52% since the year began. Nevertheless, the stocks have risen 175.52% over the past one year. While a 52-week high of $4.65 was reached on 04/05/24, a 52-week low of $1.25 was recorded on 01/23/24. SMA at 50 days reached $2.53, while 200 days put it at $1.74. A total of 0.25 million shares were traded, compared to the trading of 0.23 million shares in the previous session.
Levels Of Support And Resistance For CDXC Stock
The 24-hour chart illustrates a support level at 3.82, which if violated will result in even more drops to 3.70. On the upside, there is a resistance level at 4.06. A further resistance level may holdings at 4.18. The Relative Strength Index (RSI) on the 14-day chart is 62.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.97%. Stochastics %K at 49.77% indicates the stock is a holding.
The most recent change occurred on February 14, 2019 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $7 price target.
